BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 27555590)

  • 1. Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
    Ulges A; Witsch EJ; Pramanik G; Klein M; Birkner K; Bühler U; Wasser B; Luessi F; Stergiou N; Dietzen S; Brühl TJ; Bohn T; Bündgen G; Kunz H; Waisman A; Schild H; Schmitt E; Zipp F; Bopp T
    Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10145-50. PubMed ID: 27555590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of RORγt
    Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
    Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation.
    Gibson SA; Yang W; Yan Z; Liu Y; Rowse AL; Weinmann AS; Qin H; Benveniste EN
    J Immunol; 2017 Jun; 198(11):4244-4254. PubMed ID: 28468969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation.
    Jang SW; Hwang SS; Kim HS; Lee KO; Kim MK; Lee W; Kim K; Lee GR
    Exp Mol Med; 2017 Sep; 49(9):e375. PubMed ID: 28883547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity.
    DiToro D; Harbour SN; Bando JK; Benavides G; Witte S; Laufer VA; Moseley C; Singer JR; Frey B; Turner H; Bruning J; Darley-Usmar V; Gao M; Conover C; Hatton RD; Frank S; Colonna M; Weaver CT
    Immunity; 2020 Apr; 52(4):650-667.e10. PubMed ID: 32294406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of experimental autoimmune encephalomyelitis by β-elemene treatment is associated with Th17 and Treg cell balance.
    Zhang R; Tian A; Zhang H; Zhou Z; Yu H; Chen L
    J Mol Neurosci; 2011 May; 44(1):31-40. PubMed ID: 21246417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3.
    Zhu E; Wang X; Zheng B; Wang Q; Hao J; Chen S; Zhao Q; Zhao L; Wu Z; Yin Z
    J Immunol; 2014 Jun; 192(12):5599-609. PubMed ID: 24842756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo.
    Duarte JH; Di Meglio P; Hirota K; Ahlfors H; Stockinger B
    PLoS One; 2013; 8(11):e79819. PubMed ID: 24244565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitavastatin ameliorates autoimmune neuroinflammation by regulating the Treg/Th17 cell balance through inhibition of mevalonate metabolism.
    Prado DS; Damasceno LEA; Sonego AB; Rosa MH; Martins TV; Fonseca MDM; Cunha TM; Cunha FQ; Alves-Filho JC
    Int Immunopharmacol; 2021 Feb; 91():107278. PubMed ID: 33341737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23.
    Grifka-Walk HM; Giles DA; Segal BM
    Eur J Immunol; 2015 Oct; 45(10):2780-6. PubMed ID: 26220255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
    Takada I; Yogiashi Y; Makishima M
    Immunobiology; 2016 Feb; 221(2):188-92. PubMed ID: 26386981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lung.
    Glenn JD; Liu C; Whartenby KA
    J Leukoc Biol; 2019 May; 105(5):829-841. PubMed ID: 30762897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice.
    Sun Y; Tian T; Gao J; Liu X; Hou H; Cao R; Li B; Quan M; Guo L
    J Neuroimmunol; 2016 Mar; 292():58-67. PubMed ID: 26943960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis Toxin Inhibits Encephalitogenic T-Cell Infiltration and Promotes a B-Cell-Driven Disease during Th17-EAE.
    Maria Z; Turner E; Agasing A; Kumar G; Axtell RC
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid synthase regulates the pathogenicity of Th17 cells.
    Young KE; Flaherty S; Woodman KM; Sharma-Walia N; Reynolds JM
    J Leukoc Biol; 2017 Nov; 102(5):1229-1235. PubMed ID: 28848043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
    Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
    Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of lncRNA-1700040D17Rik in Th17 cell differentiation and the pathogenesis of EAE.
    Guo W; Lei W; Yu D; Ge Y; Chen Y; Xue W; Li Q; Li S; Gao X; Yao W
    Int Immunopharmacol; 2017 Jun; 47():141-149. PubMed ID: 28395256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.